APO RESEARCH · REPORT
Trazodone Hydrochloride (API)
Trazodone, a phenylpiperazine–triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Product & engineering
Understand the product.
Trazodone, a phenylpiperazine–triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Trazodone hydrochloride is an antidepressant chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents. Trazodone hydrochloride is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl] propyl]-1,2,4-triazolo[4,3-a]pyridin-3 (2H)-one hydrochloride. It is a white odorless crystalline powder which is freely soluble in water.
This report covers Trazodone Hydrochloride (API) (CAS Number: 25332-39-2) and Trazodone API (CAS Number: 19794-93-5).
Selected research
Market Structure
Global Trazodone Hydrochloride (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Trazodone, a phenylpiperazine–triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Trazodone hydrochloride is an antidepressant chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents. Trazodone hydrochloride is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl] propyl]-1,2,4-triazolo[4,3-a]pyridin-3 (2H)-one hydrochloride. It is a white odorless crystalline powder which is freely soluble in water.
This report covers Trazodone Hydrochloride (API) (CAS Number: 25332-39-2) and Trazodone API (CAS Number: 19794-93-5).
Read the full market overview
Trazodone hydrochloride (API) consumed in USA are mostly imported from overseas. Major companies are Angelini, Mylan, SST Corporation, The Piramal Group. The sales market share of the four companies has reached 53%. The local factory, Teva occupied about 40% market share.
This report provides an overview of the global Trazodone Hydrochloride (API) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Trazodone Hydrochloride (API) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Trazodone Hydrochloride (API) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Trazodone Hydrochloride (API) market size, projected growth trends, production technologies, key applications, and end-use industries.
Trazodone Hydrochloride (API) Segment by Company
Teva
Angelini
Mylan
Fermion
The Piramal Group
Trazodone Hydrochloride (API) Segment by Type
Trazodone Hydrochloride (API)
Others
Trazodone Hydrochloride (API) Segment by Application
Antidepression
Anxiolytic
Hypnotic
Others
Trazodone Hydrochloride (API) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Trazodone Hydrochloride (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Trazodone Hydrochloride (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Trazodone Hydrochloride (API).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Trazodone Hydrochloride (API) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Trazodone Hydrochloride (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Trazodone Hydrochloride (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Trazodone Hydrochloride (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Trazodone Hydrochloride (API)
- Others
Applications
- Antidepression
- Anxiolytic
- Hypnotic
- Others
Companies covered
- Teva
- Angelini
- Mylan
- Fermion
- The Piramal Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Trazodone Hydrochloride (API) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Trazodone Hydrochloride (API) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Trazodone Hydrochloride (API) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Trazodone Hydrochloride (API) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Trazodone Hydrochloride (API) Market Dynamics
- 2.1 Trazodone Hydrochloride (API) Industry Trends
- 2.2 Trazodone Hydrochloride (API) Industry Drivers
- 2.3 Trazodone Hydrochloride (API) Industry Opportunities and Challenges
- 2.4 Trazodone Hydrochloride (API) Industry Restraints
3 Trazodone Hydrochloride (API) Market by Manufacturers
- 3.1 Global Trazodone Hydrochloride (API) Revenue by Manufacturers (2021-2026)
- 3.2 Global Trazodone Hydrochloride (API) Sales by Manufacturers (2021-2026)
- 3.3 Global Trazodone Hydrochloride (API) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Trazodone Hydrochloride (API) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Trazodone Hydrochloride (API) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Trazodone Hydrochloride (API) Manufacturers, Product Type & Application
- 3.7 Global Trazodone Hydrochloride (API) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Trazodone Hydrochloride (API) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Trazodone Hydrochloride (API) Players Market Share by Revenue in 2025
- 3.8.3 2025 Trazodone Hydrochloride (API) Tier 1, Tier 2, and Tier 3
4 Trazodone Hydrochloride (API) Market by Type
- 4.1 Trazodone Hydrochloride (API) Type Introduction
- 4.1.1 Trazodone Hydrochloride (API)
- 4.1.2 Others
- 4.2 Global Trazodone Hydrochloride (API) Sales by Type
- 4.2.1 Global Trazodone Hydrochloride (API) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Trazodone Hydrochloride (API) Sales by Type (2021-2032)
- 4.2.3 Global Trazodone Hydrochloride (API) Sales Market Share by Type (2021-2032)
- 4.3 Global Trazodone Hydrochloride (API) Revenue by Type
- 4.3.1 Global Trazodone Hydrochloride (API) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Trazodone Hydrochloride (API) Revenue by Type (2021-2032)
- 4.3.3 Global Trazodone Hydrochloride (API) Revenue Market Share by Type (2021-2032)
5 Trazodone Hydrochloride (API) Market by Application
- 5.1 Trazodone Hydrochloride (API) Application Introduction
- 5.1.1 Antidepression
- 5.1.2 Anxiolytic
- 5.1.3 Hypnotic
- 5.1.4 Others
- 5.2 Global Trazodone Hydrochloride (API) Sales by Application
- 5.2.1 Global Trazodone Hydrochloride (API) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Trazodone Hydrochloride (API) Sales by Application (2021-2032)
- 5.2.3 Global Trazodone Hydrochloride (API) Sales Market Share by Application (2021-2032)
- 5.3 Global Trazodone Hydrochloride (API) Revenue by Application
- 5.3.1 Global Trazodone Hydrochloride (API) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Trazodone Hydrochloride (API) Revenue by Application (2021-2032)
- 5.3.3 Global Trazodone Hydrochloride (API) Revenue Market Share by Application (2021-2032)
6 Global Trazodone Hydrochloride (API) Sales by Region
- 6.1 Global Trazodone Hydrochloride (API) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Trazodone Hydrochloride (API) Sales by Region (2021-2032)
- 6.2.1 Global Trazodone Hydrochloride (API) Sales by Region (2021-2026)
- 6.2.2 Global Trazodone Hydrochloride (API) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Trazodone Hydrochloride (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Trazodone Hydrochloride (API) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Trazodone Hydrochloride (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Trazodone Hydrochloride (API) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Trazodone Hydrochloride (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Trazodone Hydrochloride (API) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Trazodone Hydrochloride (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Trazodone Hydrochloride (API) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Trazodone Hydrochloride (API) Revenue by Region
- 7.1 Global Trazodone Hydrochloride (API) Revenue by Region
- 7.1.1 Global Trazodone Hydrochloride (API) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Trazodone Hydrochloride (API) Revenue by Region (2021-2026)
- 7.1.3 Global Trazodone Hydrochloride (API) Revenue by Region (2027-2032)
- 7.1.4 Global Trazodone Hydrochloride (API) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Trazodone Hydrochloride (API) Revenue (2021-2032)
- 7.2.2 North America Trazodone Hydrochloride (API) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Trazodone Hydrochloride (API) Revenue (2021-2032)
- 7.3.2 Europe Trazodone Hydrochloride (API) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Trazodone Hydrochloride (API) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Trazodone Hydrochloride (API) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Trazodone Hydrochloride (API) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Trazodone Hydrochloride (API) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva
- 8.1.1 Teva Company Information
- 8.1.2 Teva Business Overview
- 8.1.3 Teva Trazodone Hydrochloride (API) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Trazodone Hydrochloride (API) Product Portfolio
- 8.1.5 Teva Recent Developments
- 8.2 Angelini
- 8.2.1 Angelini Company Information
- 8.2.2 Angelini Business Overview
- 8.2.3 Angelini Trazodone Hydrochloride (API) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Angelini Trazodone Hydrochloride (API) Product Portfolio
- 8.2.5 Angelini Recent Developments
- 8.3 Mylan
- 8.3.1 Mylan Company Information
- 8.3.2 Mylan Business Overview
- 8.3.3 Mylan Trazodone Hydrochloride (API) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Mylan Trazodone Hydrochloride (API) Product Portfolio
- 8.3.5 Mylan Recent Developments
- 8.4 Fermion
- 8.4.1 Fermion Company Information
- 8.4.2 Fermion Business Overview
- 8.4.3 Fermion Trazodone Hydrochloride (API) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Fermion Trazodone Hydrochloride (API) Product Portfolio
- 8.4.5 Fermion Recent Developments
- 8.5 The Piramal Group
- 8.5.1 The Piramal Group Company Information
- 8.5.2 The Piramal Group Business Overview
- 8.5.3 The Piramal Group Trazodone Hydrochloride (API) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 The Piramal Group Trazodone Hydrochloride (API) Product Portfolio
- 8.5.5 The Piramal Group Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Trazodone Hydrochloride (API) Value Chain Analysis
- 9.1.1 Trazodone Hydrochloride (API) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Trazodone Hydrochloride (API) Production Mode & Process
- 9.2 Trazodone Hydrochloride (API) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Trazodone Hydrochloride (API) Distributors
- 9.2.3 Trazodone Hydrochloride (API) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst